Aortic Valve Regurgitation
23
9
9
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 23 trials
100.0%
+13.5% vs benchmark
4%
1 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (23)
J-Valve Transfemoral Pivotal Study
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
JOURNEY LVAD: JOURNEY Left Ventricular Assist Device
Early Aortic vaLve surgEry Versus wAtchful waitiNg Strategy in Severe Asymptomatic aOrtic reguRgitation
Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease
Evaluation of Safety and Effectiveness of the EMBLOK EPS Compared With No Cerebral Embolic Protection During TAVR
Clinical Investigation for the PoliaValve Aortic Heart Valve- India
Left Ventricular Reverse Remodeling Evaluation After Surgical Correction of Aortic Regurgitation
Clinical Evaluation of the Free Margin Cusp Sizer (CALIBRATE)
Aortic or Mitral Valve Replacement With the Braile Biomédica® Bovine Pericardium Valvular Bioprosthesis
Trifecta™ Long Term Follow-Up (LTFU) Study
Clinical Trial Evaluating the Safety and Efficacy of Artificial Polymer Heart Valve for the Treatment of Aortic Valve Disease
Evaluating the Safety and Efficacy of Prosthetic Polymer Heart Valves for the Treatment of Aortic Valve Disease
CT Scan Sizing for Perceval Sutureless Valve
A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease
Transcatheter Aortic Valve Replacement for Pure Severe Aortic Valve Regurgitation
TAVIS Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease
Anticoagulation for Aortic Bioprosthesis (ANTIPRO)
Hemodynamic Matched Comparison of the Balloon-Expandable Transcatheter Heart Valves Myval and Sapien-3 for the Treatment of Aortic Stenosis
Protocoled Quantitative Assessment of Aortic Regurgitation Using Videodensitometry in a Multicontinental Trial in Rotterdam, Montreal, Yamaguchi, Segeberg, Amsterdam.